CYP2C19 and depressive symptom measurement: CYP2C19 is an enzyme involved in the metabolism of several drugs used for psychiatric disorders, including benzodiazepines and selective serotonin receptor inhibitors (SSRI) [58] and elevated expression has been associated with lower hippocampal volume in mice [59] and increased enzymatic capacity is associated with depression in humans [60].